Find clinical trials for Triple Negative Breast Cancer in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Paris, Île-de-France, FRA:
This is a phase II study, preceded by a safety run-in, with two independent cohorts (cohort A in early Triple Negative Breast...
Phase 2
Paris, France and 1 other location
CUPCAKE is a randomized, non-comparative, multicenter, proof-of-concept phase II trial, using the Trials within Cohorts concept(1) to assess the clin...
Paris, France and 12 other locations
ISIdE is an European, multicentric study that aims to assess the efficacy of Sacituzumab Govitecan (SG) in locally advanced or metastatic triple...
Phase 3
Villejuif, France
Choice Of the Most Active Strategies for Short term recurring Triple Negative Breast Cancer:A phase Ib/II, open-l-...
Phase 1, Phase 2
Villejuif, France
This study aims to evaluate the efficacy and safety of preoperative Durvalumab in patients with early small (cT1N0) triple negative ...
Phase 2
Villejuif, France and 2 other locations
is an adenosine-generating enzyme overexpressed in several cancers and associated with poor prognosis and reduced anti-tumor...
Phase 1, Phase 2
Paris, France and 15 other locations
Triple-negative breast cancer (TNBC) is a group of tumors that occurs mainly in young, premenopausal wom ...
Phase 2
Levallois-Perret, France and 43 other locations
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Saint-Cloud, France and 197 other locations
for with primary objective to evaluate the efficacy of PLX038 on response rate for patients with pretreated, metastatic or locally advanced triple...
Phase 2
Paris, France and 1 other location
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
Paris, France and 283 other locations
Clinical trials
Research sites
Resources
Legal